Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ceramide mediates caspase-independent programmed cell death.

Lutz Thon1, Heike Möhlig, Sabine Mathieu

  • 1Institut für Immunologie, Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|December 2, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Crosstalk Between <i>Mycobacterium abscessus</i> and Immune Cells: Exploring Novel Interaction Modalities.

Cells·2025
Same author

Microenvironment-Driven Mast Cell Plasticity: Insights From Cytokine-Activated Gene Signatures in Skin and Respiratory Diseases.

Allergy·2025
Same author

Circulating CD8 T cells from patients with mild-to-moderate psoriasis are functionally impaired.

Frontiers in immunology·2025
Same author

Cancer cell cooperation: tumor cells team up to scavenge nutrients to ensure proliferation despite starvation.

Signal transduction and targeted therapy·2025
Same author

Comparing novel treatments in chronic spontaneous urticaria: A critical appraisal of Bruton's tyrosine kinase inhibitors versus anti-cytokine biologics in clinical trials.

Clinical and translational allergy·2025
Same author

Mannose-6-phosphate attenuates acute lung injury by competitive release of acid sphingomyelinase from the mannose-6-phosphate receptor in endothelial caveolae.

The European respiratory journal·2025

Ceramide mediates a distinct form of programmed cell death (PCD) that bypasses caspases. Inhibiting ceramide accumulation protects cells, suggesting novel therapeutic strategies for tumor cell death.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Immunology

Background:

  • Sphingolipid ceramide's role in cell death is debated, particularly its involvement in apoptosis.
  • Tumor cell survival presents a significant challenge in cancer therapy.

Purpose of the Study:

  • To investigate ceramide's causative role in programmed cell death (PCD).
  • To explore ceramide's function in caspase-independent cell death pathways.
  • To assess the therapeutic potential of targeting the ceramide pathway in tumors.

Main Methods:

  • Utilized various cell lines (L929, NIH3T3, Jurkat) under conditions inhibiting apoptosis.
  • Manipulated intracellular ceramide levels using genetic (deficient/overexpressing cells), pharmacological, and RNA interference methods.
  • Investigated the involvement of receptor-interacting protein 1 (RIP1) and mitochondria (Bcl-2) in the ceramide death pathway.

Related Experiment Videos

Main Results:

  • Tumor Necrosis Factor (TNF) induces caspase-independent PCD by increasing intracellular ceramide levels across multiple cell types.
  • Preventing ceramide accumulation significantly enhances cell survival, confirming ceramide's necessity for this death pathway.
  • RIP1-deficient cells resist caspase-independent PCD, while Bcl-2 overexpression offers partial protection, implicating RIP1 and mitochondria.
  • Caspases appear to suppress the ceramide death pathway under physiological conditions.

Conclusions:

  • Ceramide is a key mediator of a distinct, caspase-independent programmed cell death pathway.
  • Targeting the ceramide pathway effectively reduces tumor cell clonogenic survival, offering potential for novel cancer therapies.